In 2012, Sweden made its first family planning commitment by pledging to spend US$40 million per year on contraceptives and increase its annual contribution of US$450 million to MDGs 4 and 5. In 2017, the government of Sweden revitalized its family planning commitment, increasing its global sexual and reproductive health rights (SRHR) support by an additional US$24 million. Sweden also increased contributions to UNFPA, WHO, and UNESCO. Meanwhile, the Swedish International Development Cooperation Agency (SIDA) allocated an extra US$1.4 million to SRHR and increased funding to civil society organizations, including IPPF, International HIV/AIDS Alliance, and IPAS. Sweden took the lead in organizing the She Decides conference - the beginning of a global movement for girl's and women's access to education and information about her body, modern contraception, and safe abortion.
Sweden FP2020 Commitment
Sweden’s priority is to work in the most effective way for the rights and improved health of women and girls in the most vulnerable countries in Africa.
Donor Government Assistance for Family Planning in 2013
Sweden Financial FP2020 Commitment Update
Sweden Policy FP2020 Commitment Update
No major shifts in resource allocation to RMNCH are presently expected; the focus will remain on SRHR and MDG 4 & 5.
Donor Government Assistance for Family Planning in 2015
Family Planning Summit 2017: Sweden FP2020 Commitment
Government of Sweden's Family Planning 2020 commitment delivered by Johannes Oljelund at the Family Planning Summit in London, UK on July 11, 2017
Sweden Revitalized FP2020 Commitment
Sweden, together with Belgium, Denmark and the Netherlands, organized the She-Decides conference - the beginning of a global movement for girl’s and women’s access to education and information about her body, modern contraception and safe abortion, complementing the aim of FP2020.
Implant Access Program: Expanding Family Planning Options for Women
A group of public and private organizations, including Sweden, have collaborated to make Bayer’s Jadelle® and MSD’s Implanon NXT® available to women in the world’s poorest countries at price reductions of approximately 50% through 2018 (price reductions subsequently extended to 2023).